Pharmafile Logo
Pharmafocus logo
Advanced Search
ralf_huss

German biotech Apceth appoints Prof. Ralf Huss

October 19, 2011
Research and Development appointment, research and development

Munich-based biotech Apceth has appointed Prof Ralf Huss to its management board. Prof Huss moves to the company from Roche, …

Appointment
iPad graphic

Digital Pharma: It’s not about the brand website

October 19, 2011
Sales and Marketing Digital Pharma blog

The last few years have seen an explosion of interest in digital marketing in the pharma sector, reflecting the wider …

Feature

Byetta approved for use with insulin

October 19, 2011
Amylin, GLP-1, diabetes, lilly

The FDA has approved the use of Lilly and Amylin’s diabetes treatment Byetta as an add-on therapy to insulin glargine.The …

News
Lundbeck headquarters, Denmark

Lundbeck establishes research centre in China

October 18, 2011
Research and Development Brain disorders, CNS, China, Lundbeck, Shanghai, emerging markets

Lundbeck has set up a new research centre in China, joining a wave of pharma companies investing in the region. The …

News

KV Pharma sues ex-chief exec to recoup compensation package

October 18, 2011
Ethex, KV Pharma, Marc Hermelin

US drugmaker KV Pharmaceutical is suing its former chief executive Marc Hermelin to avoid paying him a retirement and compensation …

News

GSK planning job cuts at Quebec vaccines plant

October 18, 2011
Manufacturing and Production Canada, GSK, Quebec, vaccines

GlaxoSmithKline has decided to cut around 9% of its workforce in Quebec City, Canada, with a vaccines manufacturing plant bearing …

News

Angel Bio plans joint venture with Russian drugmaker

October 18, 2011
Manufacturing and Production Angel Biotechnology, Materia Medica, Russia, biologics

UK contract manufacturing organisation Angel Biotechnology has agreed to set up a joint venture with Russian counterpart Materia Medica Holding …

News
Byetta

NICE recommends Lilly’s long-acting Bydureon

October 18, 2011
Sales and Marketing Bydureon, NICE, diabetes

NICE has recommended Eli Lilly’s long-acting diabetes drug Bydureon after the failure of oral treatments. Bydureon (exenatide) – a long-acting …

News
Professor Malcolm Grant

Grant nominated for key NHS Commissioning Board post

October 18, 2011
Commissioning Board, Malcolm Grant, NHS, Nicholson

The government has named its choice for one of the key roles at the new NHS Commissioning Board. Professor Malcolm …

News

EMA resources stretched by Mediator scandal

October 18, 2011
Research and Development, Sales and Marketing EMA, Mediator

The European Medicines Agency has been forced to use ‘considerable resources’ to deal with a flood of enquiries over Mediator …

News

Pharma Brands – join the live discussion on Twitter

October 17, 2011
Sales and Marketing branding, brands

Do pharma marketers need to kill off the ‘smiley happy people’ and update their approach to branding?  InPharm will host …

Feature
Roche

Roche buys US firm Anadys for $230 million

October 17, 2011
Research and Development, Sales and Marketing Roche, hepatitis C

Roche has acquired US firm Anadys for $230 million, bolstering its infectious drugs pipeline. California-based Anadys develops oral, small molecule …

News

Russian diabetes market to grow to $1.7 billion

October 17, 2011
Sales and Marketing Russia, diabetes

Russia’s diabetes market is set be worth $1.7 billion by 2015, according to a new report. Industry analysts Decision Resources’ …

News

Frontera appoints creative director

October 14, 2011
Medical Communications appointment, medical communications

Covent Garden-based comms agency Frontera has appointed Bruno Cepollina as creative director. The former creative partner at McCann Healthcare is …

Appointment

Health service’s £1bn patent expiry windfall

October 14, 2011
Sales and Marketing generics, patent expiry

Patent expiries could shave £1 billion from  the NHS drugs bill, and could yield major savings by 2015 for the …

Feature

Pfizer to research prescription drug costs for the elderly

October 14, 2011
Sales and Marketing Pfizer

Pfizer has signed a five-year research pact with US healthcare insurer Humana to investigate treatment costs for the elderly. The …

News

Genzyme completes expansion at Waterford plant

October 14, 2011
Manufacturing and Production Genzyme, Sanofi

Sanofi’s Genzyme unit has officially opened a €150 million expansion at its ten-year-old biotechnology facility in Waterford, Ireland that will …

News
Yervoy

NICE: Bristol-Myers Squibb’s Yervoy too costly

October 14, 2011
Sales and Marketing NICE, Yervoy

Bristol Myers Squibb has failed to win NICE backing for its melanoma drug Yervoy after the Institute judged its £80,000 …

News
Avastin

NHS regions back Avastin for eye disease

October 14, 2011
Sales and Marketing avastin

Regional NHS authorities around England are approving the use of Avastin instead of Lucentis for ophthalmology patients. A number of …

News
Kindle Fire

Keep taking the tablets

October 13, 2011
Sales and Marketing ipad, tablet pc

Online giant Amazon has just launched Fire, its rival to Apple’s trendsetting iPad, upping the ante in the ‘tablet’ market. …

Feature
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026